TY - JOUR
T1 - Quantitation of endogenous peptides using mass spectrometry based methods
AU - Romanova, Elena V.
AU - Dowd, Sarah E.
AU - Sweedler, Jonathan V.
N1 - Funding Information:
This work was supported by Award Number P30 DA018310 from the National Institute on Drug Abuse and by National Science Foundation Division of Chemistry under grant CHE-11-11705 (with co-funding from the Division of Biological Infrastructure). The content is solely the responsibility of the authors and does not necessarily represent the official views of the award agencies.
PY - 2013/10
Y1 - 2013/10
N2 - The mass spectrometry-based 'omics' sub-discipline that focuses on comprehensive, often exploratory, analyses of endogenous peptides involved in cell-to-cell communication is oftentimes referred to as peptidomics. Although the progress in bioanalytical technology development for peptide discovery has been tremendous, perhaps the largest advances have involved robust quantitative mass spectrometric approaches and data mining algorithms. These efforts have accelerated the discovery and validation of biomarkers, functionally important posttranslational modifications, and unexpected molecular interactions, information that aids drug development. In this article we outline the current approaches used in quantitative peptidomics and the technical challenges that stimulate new advances in the field, while also reviewing the newest literature on functional characterizations of endogenous peptides using quantitative mass spectrometry.
AB - The mass spectrometry-based 'omics' sub-discipline that focuses on comprehensive, often exploratory, analyses of endogenous peptides involved in cell-to-cell communication is oftentimes referred to as peptidomics. Although the progress in bioanalytical technology development for peptide discovery has been tremendous, perhaps the largest advances have involved robust quantitative mass spectrometric approaches and data mining algorithms. These efforts have accelerated the discovery and validation of biomarkers, functionally important posttranslational modifications, and unexpected molecular interactions, information that aids drug development. In this article we outline the current approaches used in quantitative peptidomics and the technical challenges that stimulate new advances in the field, while also reviewing the newest literature on functional characterizations of endogenous peptides using quantitative mass spectrometry.
UR - http://www.scopus.com/inward/record.url?scp=84887200580&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84887200580&partnerID=8YFLogxK
U2 - 10.1016/j.cbpa.2013.05.030
DO - 10.1016/j.cbpa.2013.05.030
M3 - Review article
C2 - 23790312
AN - SCOPUS:84887200580
SN - 1367-5931
VL - 17
SP - 801
EP - 808
JO - Current Opinion in Chemical Biology
JF - Current Opinion in Chemical Biology
IS - 5
ER -